Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Not yet recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 2Warts 1Triple Negative Breast Neoplasms 1Coronavirus Infections 1COVID-19 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Ivermectin × Clear all
NCT05318469 2026-05-06

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Cedars-Sinai Medical Center

Phase 1/2 Recruiting
34 enrolled
Breast

Triple Negative Breast Neoplasms

NCT07487805 2026-03-23

ICONIC

University of Florida

Phase 2 Not yet recruiting
80 enrolled
Tumor-Agnostic

Neoplasms

NCT07396714 2026-02-09

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Assiut University

Phase EARLY_PHASE1 Not yet recruiting
88 enrolled

Warts

NCT04447235 2022-08-09

TITAN

Instituto do Cancer do Estado de São Paulo

Phase 2 Terminated
77 enrolled

COVID-19, Neoplasms, Coronavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡